19-3595796-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000589966.1(TBXA2R):​c.535T>C​(p.Tyr179His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.626 in 1,610,200 control chromosomes in the GnomAD database, including 324,213 homozygotes. In-silico tool predicts a benign outcome for this variant. 9/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.65 ( 33368 hom., cov: 33)
Exomes 𝑓: 0.62 ( 290845 hom. )

Consequence

TBXA2R
ENST00000589966.1 missense

Scores

8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.82

Publications

69 publications found
Variant links:
Genes affected
TBXA2R (HGNC:11608): (thromboxane A2 receptor) This gene encodes a member of the G protein-coupled receptor family. The protein interacts with thromboxane A2 to induce platelet aggregation and regulate hemostasis. A mutation in this gene results in a bleeding disorder. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
TBXA2R Gene-Disease associations (from GenCC):
  • qualitative platelet defect
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • bleeding diathesis due to thromboxane synthesis deficiency
    Inheritance: Unknown, AD Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • schizophrenia
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.0298587E-6).
BP6
Variant 19-3595796-A-G is Benign according to our data. Variant chr19-3595796-A-G is described in ClinVar as Benign. ClinVar VariationId is 263269.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.771 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000589966.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBXA2R
NM_001060.6
MANE Select
c.924T>Cp.Tyr308Tyr
synonymous
Exon 3 of 3NP_001051.1
TBXA2R
NM_201636.3
c.924T>Cp.Tyr308Tyr
synonymous
Exon 3 of 4NP_963998.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBXA2R
ENST00000589966.1
TSL:1
c.535T>Cp.Tyr179His
missense
Exon 2 of 2ENSP00000468145.1
TBXA2R
ENST00000375190.10
TSL:1 MANE Select
c.924T>Cp.Tyr308Tyr
synonymous
Exon 3 of 3ENSP00000364336.4
TBXA2R
ENST00000411851.3
TSL:2
c.924T>Cp.Tyr308Tyr
synonymous
Exon 3 of 4ENSP00000393333.2

Frequencies

GnomAD3 genomes
AF:
0.649
AC:
98634
AN:
151994
Hom.:
33324
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.777
Gnomad AMI
AF:
0.460
Gnomad AMR
AF:
0.536
Gnomad ASJ
AF:
0.625
Gnomad EAS
AF:
0.180
Gnomad SAS
AF:
0.462
Gnomad FIN
AF:
0.627
Gnomad MID
AF:
0.706
Gnomad NFE
AF:
0.652
Gnomad OTH
AF:
0.655
GnomAD2 exomes
AF:
0.564
AC:
135033
AN:
239524
AF XY:
0.568
show subpopulations
Gnomad AFR exome
AF:
0.787
Gnomad AMR exome
AF:
0.381
Gnomad ASJ exome
AF:
0.621
Gnomad EAS exome
AF:
0.188
Gnomad FIN exome
AF:
0.629
Gnomad NFE exome
AF:
0.654
Gnomad OTH exome
AF:
0.605
GnomAD4 exome
AF:
0.623
AC:
908536
AN:
1458088
Hom.:
290845
Cov.:
103
AF XY:
0.620
AC XY:
449455
AN XY:
725094
show subpopulations
African (AFR)
AF:
0.789
AC:
26403
AN:
33444
American (AMR)
AF:
0.402
AC:
17783
AN:
44238
Ashkenazi Jewish (ASJ)
AF:
0.617
AC:
16070
AN:
26056
East Asian (EAS)
AF:
0.174
AC:
6889
AN:
39598
South Asian (SAS)
AF:
0.481
AC:
41210
AN:
85718
European-Finnish (FIN)
AF:
0.627
AC:
32895
AN:
52440
Middle Eastern (MID)
AF:
0.663
AC:
3822
AN:
5766
European-Non Finnish (NFE)
AF:
0.655
AC:
726969
AN:
1110634
Other (OTH)
AF:
0.606
AC:
36495
AN:
60194
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
23760
47519
71279
95038
118798
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18768
37536
56304
75072
93840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.649
AC:
98729
AN:
152112
Hom.:
33368
Cov.:
33
AF XY:
0.642
AC XY:
47749
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.778
AC:
32284
AN:
41508
American (AMR)
AF:
0.535
AC:
8177
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.625
AC:
2168
AN:
3468
East Asian (EAS)
AF:
0.180
AC:
929
AN:
5162
South Asian (SAS)
AF:
0.462
AC:
2229
AN:
4824
European-Finnish (FIN)
AF:
0.627
AC:
6639
AN:
10590
Middle Eastern (MID)
AF:
0.690
AC:
203
AN:
294
European-Non Finnish (NFE)
AF:
0.652
AC:
44302
AN:
67964
Other (OTH)
AF:
0.652
AC:
1380
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1692
3383
5075
6766
8458
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
774
1548
2322
3096
3870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.651
Hom.:
70273
Bravo
AF:
0.646
TwinsUK
AF:
0.653
AC:
2423
ALSPAC
AF:
0.653
AC:
2515
ESP6500AA
AF:
0.798
AC:
3482
ESP6500EA
AF:
0.655
AC:
5600
ExAC
AF:
0.569
AC:
68510
Asia WGS
AF:
0.395
AC:
1377
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28709878, 10830912)

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
9.4
DANN
Benign
0.80
FATHMM_MKL
Benign
0.045
N
LIST_S2
Benign
0.20
T
MetaRNN
Benign
0.0000010
T
PhyloP100
2.8
Sift4G
Benign
0.20
T
Vest4
0.22
GERP RS
3.1
Mutation Taster
=88/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4523; hg19: chr19-3595794; COSMIC: COSV59258345; COSMIC: COSV59258345; API